Application of the LymphGen classification tool to 928 clinically and genetically‐characterised cases of diffuse large B cell lymphoma (DLBCL)

We recently published results of targeted sequencing applied to 928 unselected cases of diffuse large B-cell lymphoma (DLBCL) listed in the Haematological Malignancy Research Network (HMRN) registry.1 Clustering allowed us to resolve five genomic subtypes. These subtypes shared considerable overlap with those proposed in two independent genomic studies,2, 3 suggesting there is potential to use genetics to stratify patients by both risk and...